164 related articles for article (PubMed ID: 31618444)
1. Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.
Felix AS; McLaughlin EM; Caan BJ; Cohn DE; Anderson GL; Paskett ED
Int J Cancer; 2020 Jul; 147(2):404-412. PubMed ID: 31618444
[TBL] [Abstract][Full Text] [Related]
2. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
3. Guideline-concordant treatment is associated with improved survival among women with non-endometrioid endometrial cancer.
Dholakia J; Llamocca E; Quick A; Salani R; Felix AS
Gynecol Oncol; 2020 Jun; 157(3):716-722. PubMed ID: 32217002
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
5. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.
Matsuo K; Machida H; Ragab OM; Garcia-Sayre J; Yessaian AA; Roman LD
J Surg Oncol; 2017 Sep; 116(4):482-491. PubMed ID: 28543055
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract][Full Text] [Related]
7. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
Xiang M; English DP; Kidd EA
Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Brasky TM; Cohn DE; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel C; Boggess JF; Pearl ML; Ioffe OB; Deng W; Miller DS; Brinton LA
Int J Cancer; 2018 Mar; 142(6):1102-1115. PubMed ID: 29063589
[TBL] [Abstract][Full Text] [Related]
9. Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study.
Rydzewski NR; Strohl AE; Donnelly ED; Kanis MJ; Lurain JR; Nieves-Neira W; Strauss JB
Cancer; 2016 Dec; 122(23):3724-3731. PubMed ID: 27509082
[TBL] [Abstract][Full Text] [Related]
10. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated endometrial carcinoma: a National Cancer Database analysis of prognostic factors and treatment outcomes.
AlHilli M; Elson P; Rybicki L; Amarnath S; Yang B; Michener CM; Rose PG
Int J Gynecol Cancer; 2019 Sep; 29(7):1126-1133. PubMed ID: 31422353
[TBL] [Abstract][Full Text] [Related]
12. Intra-racial disaggregation reveals associations between nativity and overall survival in women with endometrial cancer.
Mercadel AJ; Sanchez-Covarrubias AP; Medina HN; Pinheiro PS; Pinto A; George SHL; Schlumbrecht MP
Gynecol Oncol; 2023 Sep; 176():98-105. PubMed ID: 37480810
[TBL] [Abstract][Full Text] [Related]
13. Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus.
Mei S; Gibbs J; Economos K; Lee YC; Kanis MJ
J Gynecol Oncol; 2019 Jul; 30(4):e58. PubMed ID: 31074241
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.
Ayhan A; Topfedaisi Ozkan N; Öz M; Kimyon Comert G; Firat Cuylan Z; Çoban G; Turkmen O; Erdem B; Şahin H; Akbayır Ö; Dede M; Turan AT; Celik H; Güngör T; Haberal A; Arvas M; Meydanli MM
J Gynecol Oncol; 2018 Jul; 29(4):e48. PubMed ID: 29770619
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
[TBL] [Abstract][Full Text] [Related]
16. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center.
Tai YJ; Hsu HC; Chiang YC; Chen YL; Chen CA; Cheng WF
Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31323767
[TBL] [Abstract][Full Text] [Related]
17. Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer.
Tobias CJ; Chen L; Melamed A; St Clair C; Khoury-Collado F; Tergas AI; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
JAMA Netw Open; 2020 Dec; 3(12):e2028612. PubMed ID: 33295973
[TBL] [Abstract][Full Text] [Related]
18. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
19. Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States.
Vyas AM; Aroke H; Kogut S
J Natl Compr Canc Netw; 2020 Apr; 18(4):405-413. PubMed ID: 32259787
[TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative.
Felix AS; Lehman A; Foraker RE; Naughton MJ; Bower JK; Kuller L; Sarto GE; Stefanick ML; Van Horn L; Jackson RD; Paskett ED
Cancer Epidemiol; 2017 Dec; 51():62-67. PubMed ID: 29049937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]